peginesatide: Clinical Trials

8 completed. 8 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	8	Completed 8

Follow peginesatide: new trials by email Literature Review of peginesatide trials Research Report on peginesatide

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin. Peginesatide - Anemia	Phase 2	Completed	Takeda	59	2008-10-01	2012-08-15
Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. Peginesatide - Anemia	Phase 2	Completed	Takeda	102	2008-09-01	2012-07-27
Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA peginesatide, Epoetin Alfa - Anemia, Chronic Renal Failure	Phase 2	Completed	Affymax	114	2008-06-01	2012-06-29
Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Completed	Affymax	91	2006-12-01	2012-06-29
Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease Peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Completed	Takeda	22	2006-04-06	2019-03-14
Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy peginesatide - Chemotherapy Induced Anemia, Cancer	Phase 2	Completed	Affymax	60	2006-01-01	2012-12-21
Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Completed	Affymax	139	2005-09-01	2012-12-21
Peginesatide for Anemia in Chronic Hemodialysis Patients peginesatide - Anemia, Chronic Kidney Disease	Phase 2	Completed	Affymax	165	2005-07-01	2012-12-21

Conditions studied

Anemia (8)  ·  Kidney Failure, Chronic (5)  ·  Renal Insufficiency, Chronic (5)  ·  Neoplasms (1)  ·  Red-Cell Aplasia, Pure (1)  ·  Renal Insufficiency (1)

Sponsors

Affymax (5)  ·  Takeda (3)

Countries

United Kingdom (5)  ·  United States (3)  ·  Poland (2)  ·  Australia (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Romania (1)  ·  Russia (1)

Top investigators

Vice President, Clinical Development (2)

Results publications

PMID 19890127, PMID 21940838, PMID 22935486

NIH funding

2005 (3), 2008 (2)